Covid-19 roundup: FDA stamps quick OK on Roche's Actemra PhIII; AlloVir expands Baylor pact
→ The FDA has offered a quick OK for Genentech to start a Phase III trial using their rheumatoid arthritis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
